Clinical Trials Browser

Phase 1 × cixutumumab × Gastrointestinal × Clear all

NCT01008566 2016-05-12

Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular